Daphne Quimi Receives Stock Award at Amylyx Pharmaceuticals Inc (AMLX) — SEC Form 4, Jun 12, 2023
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Daphne Quimi CIK 0001543031 |
Director
|
Daphne Quimi at Amylyx Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amylyx Pharmaceuticals Inc
| 2026-06-08 | Award | — | View |
| 2025-06-09 | Award | — | View |
| 2024-06-07 | Award | — | View |
| 2024-05-16 | Buy | +$9,436 | View |
| 2022-06-10 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $26.25 | 2023-06-08 | A - Award/Grant | 16,985 A | $0.00 | 2033-06-08 | 16,985 Common Stock | Direct |
Footnotes (1)
- F1
- The shares subject to this option shall vest in full upon the earlier of (i) June 8, 2024 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Show more
Remarks
Exhibit List: Exhibit 24. This Power of Attorney was inadvertently omitted from the Form 3 filed on January 6, 2022.
Show moreRelated filings at Amylyx Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
205
institutional managers reporting a position
Largest by reported value
- Fmr Llc $300M
- Black Rock, Inc. $159M
- Perceptive Advisors Llc $150M
5%+ Holders · 13D/G
5 filers
-
Fmr Llc 15.0%
-
Black Rock, Inc. 7.1%
-
Commodore Capital Lp 5.1%
Other insiders at Amylyx Pharmaceuticals Inc
-
George M Milne Jr -$831K
-
Camille L Bedrosian -$325K
-
James M Frates -$350K
-
Gina Mazzariello -$310K
-
Justin B. Klee -$980K
GET /v1/forms/4/0000899243-23-015408
API docs
View Original SEC Filing